How much is Biomeme worth in 2026?

Biomeme has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Biomeme raised?

Biomeme has raised N/A in total funding across 1 funding rounds.

Biomeme

Diagnostic Equipment

Current Valuation

N/A

As of March 26, 2020

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC

Amount undisclosed

Last Funding

Mar 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Interested in buying or selling Biomeme shares?

Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 26, 2020	Later Stage VC	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Biomeme is currently valued at N/A as of March 26, 2020.

Explore More Data

Detailed analysis for Biomeme

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

See full funding history

What is Biomeme Worth in 2026?

Biomeme is a leading private company in the Diagnostic Equipment sector. Track Biomeme's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Biomeme Valuation is Determined

Private company valuations like Biomeme's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.